Security Snapshot

Avid Bioservices, Inc. - Common Stock, par value $0.001 per share (CDMO) Institutional Ownership

CUSIP: 05368M106

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2025

Latest Period

Q4 2025

Institutions Reporting

0

Shares (Excl. Options)

0

Price

$12.49

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
CDMO
Shares outstanding
64,369,712
Price per share
$12.49
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
0
Total reported value
$0
Share change
-134,598
Value change
-$1,531,725
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • CDMO - Avid Bioservices, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 05368M106.
  • 0 institutions reported positions in Q4 2025.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 1 to 0 between Q3 2025 and Q4 2025.
  • Reported value moved from $1,531,725 to $0.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 0 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 05368M106?
CUSIP 05368M106 identifies CDMO - Avid Bioservices, Inc. - Common Stock, par value $0.001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Avid Bioservices, Inc. - Common Stock, par value $0.001 per share (CDMO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
AltraVue Capital, LLC 5.9% $47,190,485 3,797,813 AltraVue Capital, LLC 31 Dec 2024

Institutional Holders of Avid Bioservices, Inc. - Common Stock, par value $0.001 per share (CDMO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$1,531,725 $12.49 0
2025 Q3 134,598 $1,531,725 +$1,531,725 $11.38 1
2025 Q2 0 $0 -$2,310 $12.49 0
2025 Q1 187 $2,310 -$824,589,287 $12.43 2
2024 Q4 67,862,725 $838,118,292 +$9,853,050 $12.35 195
2024 Q3 68,016,155 $773,947,096 +$65,075,263 $11.38 171
2024 Q2 65,072,173 $464,610,616 +$2,556,922 $7.14 167
2024 Q1 65,068,905 $435,959,854 +$52,291,806 $6.70 162
2023 Q4 57,332,577 $373,979,029 -$54,052,092 $6.50 171
2023 Q3 62,604,660 $590,964,703 -$26,582,219 $9.44 166
2023 Q2 64,851,861 $906,098,576 -$203,208 $13.97 164
2023 Q1 64,584,658 $1,211,388,533 -$7,196,779 $18.76 166
2022 Q4 65,304,421 $899,318,344 +$3,894,302 $13.77 162
2022 Q3 64,309,645 $1,229,047,447 +$30,714,400 $19.12 168
2022 Q2 61,099,678 $932,609,878 -$12,928,155 $15.26 180
2022 Q1 61,944,273 $1,262,212,725 -$11,767,975 $20.37 182
2021 Q4 61,292,159 $1,785,416,483 +$224,167,054 $29.18 184
2021 Q3 53,889,335 $1,161,457,403 +$19,405,092 $21.57 154
2021 Q2 52,834,820 $1,353,592,887 +$137,037,774 $25.65 167
2021 Q1 47,706,252 $870,108,293 +$164,156,116 $18.23 152
2020 Q4 39,269,337 $453,350,286 +$67,918,429 $11.54 141
2020 Q3 33,338,151 $254,061,025 +$32,454,270 $7.62 104
2020 Q2 29,117,143 $191,764,644 +$5,672,161 $6.56 95
2020 Q1 28,279,005 $144,444,796 -$6,179,021 $5.11 89
2019 Q4 28,687,052 $219,999,260 +$25,179,108 $7.67 105
2019 Q3 25,297,730 $133,946,899 +$6,955,012 $5.30 90
2019 Q2 23,840,831 $133,510,921 +$16,544,433 $5.60 86
2019 Q1 21,669,771 $92,077,139 -$4,951,613 $4.25 88
2018 Q4 22,411,743 $91,847,919 +$1,141,125 $4.10 93
2018 Q3 16,666,361 $114,325,369 +$33,609,807 $6.86 93
2018 Q2 12,063,396 $47,294,157 +$7,659,118 $3.92 68
2018 Q1 10,528,593 $30,755,800 +$28,250,800 $2.92 56
2017 Q4 257,323 $993,000 +$958,000 $3.87 3
2016 Q2 0 $0 -$17,000 $12.49 0
2016 Q1 4,000 $17,000 $4.25 1

Sponsored